• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Retraction notice to "MiR-21-3p aggravates injury in rats with acute hemorrhagic necrotizing pancreatitis by activating TRP signaling pathway" [Biomed. Pharmacother. 107 (2018) 1744-1753].

作者信息

Wang Tao, Jiang Lihua, Wei Xiaoyong, Liu Bo, Zhao Junbo, Xie Peilin, Yang Bo, Wang Lijuan

机构信息

Department of Anesthesiology, The Third Affiliated Hospital of Zhengzhou University, No. 7, Zhengzhou Kangfufront Street, Zhengzhou City 450052, Henan Province, China.

Department of Anesthesiology, The Third Affiliated Hospital of Zhengzhou University, No. 7, Zhengzhou Kangfufront Street, Zhengzhou City 450052, Henan Province, China.

出版信息

Biomed Pharmacother. 2023 Apr;160:114275. doi: 10.1016/j.biopha.2023.114275. Epub 2023 Jan 31.

DOI:10.1016/j.biopha.2023.114275
PMID:36725473
Abstract
摘要

相似文献

1
Retraction notice to "MiR-21-3p aggravates injury in rats with acute hemorrhagic necrotizing pancreatitis by activating TRP signaling pathway" [Biomed. Pharmacother. 107 (2018) 1744-1753].撤回声明：“MiR-21-3p通过激活TRP信号通路加重急性出血坏死性胰腺炎大鼠的损伤”[《生物医学与药物治疗》107 (2018) 1744 - 1753]
Biomed Pharmacother. 2023 Apr;160:114275. doi: 10.1016/j.biopha.2023.114275. Epub 2023 Jan 31.
2
MiR-21-3p aggravates injury in rats with acute hemorrhagic necrotizing pancreatitis by activating TRP signaling pathway.miR-21-3p 通过激活 TRP 信号通路加重急性出血坏死性胰腺炎大鼠的损伤。
Biomed Pharmacother. 2018 Nov;107:1744-1753. doi: 10.1016/j.biopha.2018.08.164. Epub 2018 Sep 10.
3
Retraction notice to: "Long noncoding RNA RMRP upregulation aggravates myocardial ischemia-reperfusion injury by sponging miR-206 to target ATG3 expression" [Biomed. Pharmacother. 109 (2018) 716-725].
Biomed Pharmacother. 2022 Jan;145:112510. doi: 10.1016/j.biopha.2021.112510. Epub 2021 Dec 9.
4
Retraction notice to "MiR-29b aggravates lipopolysaccharide-induced endothelial cells inflammatory damage by regulation of NF-κB and JNK signaling pathways" [Biomed. Pharmacother. 99 (2018) 451-461].对“MiR-29b通过调节NF-κB和JNK信号通路加重脂多糖诱导的内皮细胞炎症损伤”[《生物医学与药物治疗》99(2018)451-461]的撤稿通知
Biomed Pharmacother. 2022 Jul;151:112859. doi: 10.1016/j.biopha.2022.112859. Epub 2022 Mar 25.
5
Retraction notice to "LINC01116 targets miR-520a-3p and affects IL6R to promote the proliferation and migration of osteosarcoma cells through the Jak-stat signaling pathway" [Biomed. Pharmacother. 107 (2018) 270-282].
Biomed Pharmacother. 2024 Apr;173:116325. doi: 10.1016/j.biopha.2024.116325. Epub 2024 Mar 4.
6
Retraction notice to "Corrigendum to LINC01116 targets miR-520a-3p and affects IL6R to promote the proliferation and migration of osteosarcoma cells through the Jak-stat signaling pathway" [Biomed. Pharmacother. 133 (2020) 110893].
Biomed Pharmacother. 2024 Apr;173:116326. doi: 10.1016/j.biopha.2024.116326. Epub 2024 Mar 4.
7
Retraction notice to "Corrigendum to 'LINC01116 targets miR-520a-3p and affects IL6R to promote the proliferation and migration of osteosarcoma cells through the Jak-stat signaling pathway'" [Biomed. Pharmacother. 111 (2019) 1508-1508].
Biomed Pharmacother. 2024 Apr;173:116327. doi: 10.1016/j.biopha.2024.116327. Epub 2024 Mar 5.
8
Retraction notice to "MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC" Biomed. Pharmacother. 110(2019) 656-666.
Biomed Pharmacother. 2024 Aug;177:117098. doi: 10.1016/j.biopha.2024.117098. Epub 2024 Jul 5.
9
Retraction notice to "Knockdown of ANRIL aggravates HO-induced injury in PC-12 cells by targeting microRNA-125a" [Biomed. Pharmacother. 92 (2017) 952-961].
Biomed Pharmacother. 2022 Apr;148:112779. doi: 10.1016/j.biopha.2022.112779. Epub 2022 Mar 7.
10
Retraction notice to "Long non-coding RNA LINC00525 promotes the non-small cell lung cancer progression by targeting miR-338-3p/IRS2 axis" [Biomed. Pharmacother. 124 (2020) 109858].撤回通知：“长链非编码RNA LINC00525通过靶向miR-338-3p/IRS2轴促进非小细胞肺癌进展”[《生物医学与药物治疗》124卷（2020年）109858]
Biomed Pharmacother. 2023 Apr;160:114278. doi: 10.1016/j.biopha.2023.114278. Epub 2023 Jan 31.